1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the
Study
2.2. Baseline Methodology
2.3. Key Industry
Partners
2.4. Major Association
and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data Triangulation
& Validation
2.7. Assumptions and
Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, and Trends
4. Voice of Customer
5. Asia Pacific Active
Pharmaceutical Ingredients Market Outlook
5.1. Market Size &
Forecast
5.1.1. By Value
5.2. Market Share &
Forecast
5.2.1. By Method of Synthesis (Biological, Synthetic)
5.2.2. By Source (Contact Manufacturing Organizations v/s In-House
Manufacturing)
5.2.3. By Therapeutic Application (Cardiovascular Diseases, Anti-diabetic
Drugs, Oncology Drugs, Neurological Disorders, Musculoskeletal Disorders, Others)
5.2.4. By Molecule Type (Small v/s Large)
5.2.5. By Potency (Low v/s High)
5.2.6. By Drug Type (Innovator v/s Generics)
5.2.7. By Country
5.2.8. By Company (2022)
5.3. Market Map
5.3.1. By Method of
Synthesis
5.3.2. By Source
5.3.3. By Therapeutic
Application
5.3.4. By Molecule Type
5.3.5. By Potency
5.3.6. By Drug Type
5.3.7. By Country
6.
China Active Pharmaceutical Ingredients Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Method of Synthesis
6.2.2. By Source
6.2.3. By Therapeutic Application
6.2.4. By Molecule Type
6.2.5. By Potency
6.2.6. By Drug Type
7.
India Active Pharmaceutical Ingredients Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1. By Method of Synthesis
7.2.2. By Source
7.2.3. By Therapeutic Application
7.2.4. By Molecule Type
7.2.5. By Potency
7.2.6. By Drug Type
8.
Japan Active Pharmaceutical Ingredients Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1. By Method of Synthesis
8.2.2. By Source
8.2.3. By Therapeutic Application
8.2.4. By Molecule Type
8.2.5. By Potency
8.2.6. By Drug Type
9.
South Korea Active Pharmaceutical Ingredients Market
Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Method of Synthesis
9.2.2. By Source
9.2.3. By Therapeutic Application
9.2.4. By Molecule Type
9.2.5. By Potency
9.2.6. By Drug Type
10.
Taiwan Active Pharmaceutical Ingredients Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Method of Synthesis
10.2.2. By Source
10.2.3. By Therapeutic Application
10.2.4. By Molecule Type
10.2.5. By Potency
10.2.6. By Drug Type
11.
Vietnam Active Pharmaceutical Ingredients Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Method of Synthesis
11.2.2. By Source
11.2.3. By Therapeutic Application
11.2.4. By Molecule Type
11.2.5. By Potency
11.2.6. By Drug Type
12.
Philippines Active Pharmaceutical Ingredients Market
Outlook
12.1.
Market Size & Forecast
12.1.1. By Value
12.2.
Market Share & Forecast
12.2.1. By Method of Synthesis
12.2.2. By Source
12.2.3. By Therapeutic Application
12.2.4. By Molecule Type
12.2.5. By Potency
12.2.6. By Drug Type
13.
Indonesia Active Pharmaceutical Ingredients Market
Outlook
13.1.
Market Size & Forecast
13.1.1. By Value
13.2.
Market Share & Forecast
13.2.1. By Method of Synthesis
13.2.2. By Source
13.2.3. By Therapeutic Application
13.2.4. By Molecule Type
13.2.5. By Potency
13.2.6. By Drug Type
14.
Malaysia Active Pharmaceutical Ingredients Market Outlook
14.1.
Market Size & Forecast
14.1.1. By Value
14.2.
Market Share & Forecast
14.2.1. By Method of Synthesis
14.2.2. By Source
14.2.3. By Therapeutic Application
14.2.4. By Molecule Type
14.2.5. By Potency
14.2.6. By Drug Type
15.
Australia Active Pharmaceutical Ingredients Market
Outlook
15.1.
Market Size & Forecast
15.1.1. By Value
15.2.
Market Share & Forecast
15.2.1. By Method of Synthesis
15.2.2. By Source
15.2.3. By Therapeutic Application
15.2.4. By Molecule Type
15.2.5. By Potency
15.2.6. By Drug Type
16. Market Dynamics
16.1.
Drivers
16.2.
Challenges
17. Market Trends &
Developments
17.1.
Product Launches
17.2.
Mergers & Acquisitions
17.3.
Technological Advancements
18. Competitive
Landscape
18.1.1.
Cipla Limited
18.2.
Business Overview
18.3.
Product Offerings
18.4.
Recent Developments
18.5.
Financials (As Reported)
18.6.
Key Personnel
18.7.
SWOT Analysis
18.7.1.
Pfizer, Inc.
18.7.2.
Dr. Reddy's Laboratories Ltd.
18.7.3.
Symbiotica Speciality Ingredients Sdn. Bhd.
18.7.4.
ScinoPharm Taiwan Ltd
18.7.5.
Zhejiang Hisun Pharmaceutical Co. Ltd.
18.7.6.
Aurobindo Pharma Ltd.
18.7.7.
Sun Pharmaceutical Industries Ltd.
18.7.8.
Teva Pharmaceutical Industries Ltd.
18.7.9.
AbbVie Inc.
18.7.10.
AstraZeneca Plc
18.7.11.
GlaxoSmithKline Plc
18.7.12.
Sanofi S.A.
18.7.13.
Lupin Limited
18.7.14.
Nanjing Pharmaceutical Factory Co. Ltd.
Strategic Recommendations